![]() |
市場調查報告書
商品編碼
2032989
醫療認知計算市場規模、佔有率、趨勢和預測:按技術、部署模式、最終用途和地區分類(2026-2034 年)Healthcare Cognitive Computing Market Size, Share, Trends and Forecast by Technology, Deployment Mode, End Use, and Region, 2026-2034 |
||||||
2025年全球醫療認知運算市場規模為70億美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以15.29%的複合年成長率成長,到2034年達到261億美元。北美目前佔據市場主導地位,預計2025年將佔據超過38.6%的市場。推動市場發展的積極因素包括:人工智慧和巨量資料在診斷和個人化醫療領域的應用日益廣泛;對精準醫療和先進診斷技術的需求不斷成長;以及為應對勞動力短缺和提高營運效率而日益成長的自動化需求。
認知運算是一種自學習系統,它利用資料探勘、模式識別、自然語言處理、人類感官處理和系統最佳化等技術來模擬人類的思考過程。它能夠處理大量數據,以回答特定問題、提供客製化的智慧建議並輔助決策。此外,它還能分析新的模式、辨識商機並即時應對關鍵的流程挑戰。更重要的是,它透過提供高度相關、情境化且有價值的資訊來改善客戶互動。目前,認知計算已廣泛應用於醫療領域,利用歷史數據來治療患者並識別健康問題。
全球慢性病發生率的上升是推動市場發展的主要因素之一。此外,人們對基因特異性療法的需求日益成長,這些療法能夠在不損傷健康組織的情況下清除癌細胞。同時,全球醫療產業的進步也促進了市場成長。此外,第三方計算平台的使用也不斷增加,以提升患者照護。腫瘤學領域對個人化醫療的需求不斷成長,為產業投資者帶來了極具吸引力的成長機會。除此之外,醫學認知計算正被應用於個人化醫療、黑色素瘤篩檢以及電子健康記錄(EHR)數據分析。此外,全球藥物研發和併購,預計有助於提升整體盈利。
本報告分析了全球醫療保健認知運算市場各細分領域的關鍵趨勢,並對2026年至2034年進行了全球、區域和國家層面的預測。市場按技術、部署模式和最終用途進行細分。
關於該行業的競爭格局,我們檢視了主要公司的概況,包括 Apixio(Centene 公司)、蘋果、CognitiveScale、Enterra 檢驗 LLC、Google(Alphabet 公司)、Healthcare X.0 GmbH、英特爾公司、國際商業機器公司、MedWhat 和微軟公司。
The global healthcare cognitive computing market size was valued at USD 7.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 26.1 Billion by 2034, exhibiting a CAGR of 15.29% from 2026-2034. North America currently dominates the market, holding a market share of over 38.6% in 2025. The heightened adoption of AI and big data for diagnostics and personalized treatments, the rising demand for precision medicine and advanced diagnostics, and the growing need for automation to address workforce challenges and improve operational efficiency are some of the factors impacting the market positively.
Cognitive computing is a self-learning system that relies on data mining techniques, pattern recognition, natural languages, human sense processing, and system refinements to simulate the human thought process. It processes enormous amounts of data to answer specific queries, gives customized intelligent recommendations and supports decision making. It analyzes emerging patterns, spots business opportunities and handles critical process-centric issues in real-time. It also enhances customer interactions by providing relevant, contextual and valuable information. At present, cognitive computing is extensively utilized in the healthcare sector to treat patients using past data and recognize any health-related issues.
The growing prevalence of chronic diseases across the globe represents one of the key factors driving the market. Moreover, there is a rise in the demand for gene-specific treatment to eliminate cancer cells without damaging healthy tissues. This, along with advancements in the healthcare industry around the world, is propelling the growth of the market. In addition, there is an increase in the use of third computing platforms to facilitate better patient care. This, coupled with the escalating demand for personalized treatments in oncology, is offering lucrative growth opportunities to industry investors. Besides this, healthcare cognitive computing finds application in customized medicine, melanoma screening, and electronic health record (EHR) data analysis. Additionally, the increasing cost of drug discovery and clinical trials worldwide are catalyzing the demand for healthcare cognitive computing. Apart from this, governing authorities of several countries are undertaking initiatives to promote the usage of e-health technologies, which is positively influencing the market. Furthermore, key market players are focusing on mergers and acquisitions (M&A), which is projected to bolster their overall profitability.
This report provides an analysis of the key trends in each segment of the global healthcare cognitive computing market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on technology, deployment mode and end use.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Apixio (Centene Corporation), Apple Inc., CognitiveScale, Enterra Solutions LLC, Google LLC (Alphabet Inc.), Healthcare X.0 GmbH, Intel Corporation, International Business Machines Corporation, MedWhat and Microsoft Corporation.